Is Less Truly More? Reassessing Safety Analysis for HIV Patients Switching from Triple to Double Regimens with Integrase Inhibitors: A Systematic Review and Meta-Analysis

Reassessing Safety Analysis for HIV Patients Switching from Triple to Double Regimens with Integrase Inhibitors: A Systematic Review and Meta-Analysis.

This study aimed to determine if there are benefits of treatment simplification in terms of safety and tolerability to help in the decision-making in routine clinical practice and to provide the best therapeutic option for patients. This research outlines that there is still insufficient information to claim that simplifying from 3DR or 4DR to 2DR […]

Validación de una herramienta digital para la recogida de resultados reportados por los pacientes (PROs) previamente a la consulta médica en personas que viven con el VIH: “Prepara tu consulta”

Validación de una herramienta digital para la recogida de resultados reportados por los pacientes (PROs) previamente a la consulta médica en personas que viven con el VIH

“Prepara tu consulta” is a mHealth app developed to collect patient-reported outcomes (PRO) from people living with HIV (PLWH) before the physician’s visit. The validity of the app as a tool to report health-related quality of life (HRQOL) in PLWH has not been studied yet. We aimed to analyse the correlation between the app questionnaire […]

Resource utilization associated with the management of potential interactions between direct-acting antivirals for chronic hepatitis C treatment and cardiovascular and central nervous system drugs

Evaluation of the additional actions and resource utilization required for the management of potential drug-drug interactions in HCV patients showing cardiovascular and central nervous system comorbidities, treated with sofosbuvir/velpatasvir compared to glecaprevir/ pibrentasvir in routine clinical practice in Spain.

Uso de recursos y costes asociados a las comorbilidades cardiovascular, renal, ósea y neuropsiquiátrica en pacientes con infección por VIH en España

Economic impact based on a scenario analysis to estimate the cost of cardiovascular, renal, bone and neuropsychiatric comorbidities in people living with human immunodeficiency virus in a current scenario versus alternative scenarios that simulate an increase in comorbidities due to toxicity that could be associated with certain treatments, over a 10-year time horizon and from […]

Skip to content